「q」の検索結果
394件：6～10件目を表示
-
ials in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a compound ...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716_0.pdf -
Business Activities | About Senju | SENJU Pharmaceutical
Based on a sense of mission to contribute to the health of the eyes of people around the world, and a development policy that puts top priority on safety, we have always taken a pioneering path in oph
https://www.senju.co.jp/english/about/business/ -
oval in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a TRPV1 ant...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117.pdf -
ials in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a compound ...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716.pdf -
Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical
n of Information to Senju Pharmaceutical has a Customer Service Center for directly responding to inquiries from consumers and patients. The role of the Center is to contribute to the proper use of ph...
https://www.senju.co.jp/english/about/csr01.html